PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. Electronic address: czb2002@med.cornell.edu.\', \'College of Global Public Health, New York University, New York, NY, USA.\', \'Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.\', \'North American Syringe Exchange Network, Tacoma, WA, USA.\', \'Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA, USA.\', \'Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.\', \'Division of Infectious Diseases, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0376-8716(22)00060-610.1016/j.drugalcdep.2022.109323
?:doi
?:hasPublicationType
?:journal
  • Drug and alcohol dependence
is ?:pmid of
?:pmid
?:pmid
  • 35124386
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.715
?:rankingScore_hIndex
  • 142
?:title
  • Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all